First Time Loading...

Sunflower Pharmaceutical Group Co Ltd
SZSE:002737

Watchlist Manager
Sunflower Pharmaceutical Group Co Ltd Logo
Sunflower Pharmaceutical Group Co Ltd
SZSE:002737
Watchlist
Price: 30.12 CNY 2.59% Market Closed
Updated: May 13, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Sunflower Pharmaceutical Group Co Ltd

Wall Street analysts forecast Sunflower Pharmaceutical Group Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sunflower Pharmaceutical Group Co Ltd is 23.28 CNY .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
23.28 CNY
23% Downside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
23.28 CNY
23% Downside
Highest
Price Target
Not Available
Sunflower Pharmaceutical Group Co Ltd Competitors:
Price Targets
300181
Zhejiang Jolly Pharmaceutical Co Ltd
8% Downside
NATCOPHARM
Natco Pharma Ltd
6% Downside
JNJ
Johnson & Johnson
17% Upside
VETO
Vetoquinol SA
11% Upside
300181
Zhejiang Jolly Pharmaceutical Co Ltd
8% Downside
NATCOPHARM
Natco Pharma Ltd
6% Downside
JNJ
Johnson & Johnson
17% Upside
VETO
Vetoquinol SA
11% Upside
FULC
Fulcrum Therapeutics Inc
79% Upside
001630
Chongkundang Holdings Corp
17% Upside
PRPH
Prophase Labs Inc
316% Upside
603229
Zhejiang Ausun Pharmaceutical Co Ltd
78% Upside

Revenue
Forecast

Revenue Estimate
Sunflower Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Sunflower Pharmaceutical Group Co Ltd's revenue is 8%. The projected CAGR for the next 2 years is 14%.

8%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sunflower Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Sunflower Pharmaceutical Group Co Ltd's operating income is 19%. The projected CAGR for the next 5 years is -11%.

19%
Past Growth
-11%
Estimated Growth
Estimates Accuracy
10%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sunflower Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Sunflower Pharmaceutical Group Co Ltd's net income is 18%. The projected CAGR for the next 2 years is 14%.

18%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sunflower Pharmaceutical Group Co Ltd's stock price target?
Price Target
23.28 CNY

According to Wall Street analysts, the average 1-year price target for Sunflower Pharmaceutical Group Co Ltd is 23.28 CNY .

What is Sunflower Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Sunflower Pharmaceutical Group Co Ltd's revenue is 8%. The projected CAGR for the next 2 years is 14%.

What is Sunflower Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
-11%

For the last 8 years the compound annual growth rate for Sunflower Pharmaceutical Group Co Ltd's operating income is 19%. The projected CAGR for the next 5 years is -11%.

What is Sunflower Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Sunflower Pharmaceutical Group Co Ltd's net income is 18%. The projected CAGR for the next 2 years is 14%.

ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.